The shares of the cancer therapy producer were buffeted by FDA approval and dilution. Their Cesium-131 based brachytherapy solutions show a lot of promise, not only in combating prostate cancer where they get most of their revenues. The company has a chance to scale up with the FDA approval, but they will have to speed […]
Entries Tagged as 'ISR'
July 15th, 2018 · Comments Off on IsoRay Has Exciting Prospects